Literature DB >> 21091866

The pulmonary embolism rule-out criteria (PERC) rule does not safely exclude pulmonary embolism.

O Hugli1, M Righini, G Le Gal, P-M Roy, O Sanchez, F Verschuren, G Meyer, H Bounameaux, D Aujesky.   

Abstract

BACKGROUND: The Pulmonary Embolism Rule-out Criteria (PERC) rule is a clinical diagnostic rule designed to exclude pulmonary embolism (PE) without further testing. We sought to externally validate the diagnostic performance of the PERC rule alone and combined with clinical probability assessment based on the revised Geneva score.
METHODS: The PERC rule was applied retrospectively to consecutive patients who presented with a clinical suspicion of PE to six emergency departments, and who were enrolled in a randomized trial of PE diagnosis. Patients who met all eight PERC criteria [PERC((-))] were considered to be at a very low risk for PE. We calculated the prevalence of PE among PERC((-)) patients according to their clinical pretest probability of PE. We estimated the negative likelihood ratio of the PERC rule to predict PE.
RESULTS: Among 1675 patients, the prevalence of PE was 21.3%. Overall, 13.2% of patients were PERC((-)). The prevalence of PE was 5.4% [95% confidence interval (CI): 3.1-9.3%] among PERC((-)) patients overall and 6.4% (95% CI: 3.7-10.8%) among those PERC((-)) patients with a low clinical pretest probability of PE. The PERC rule had a negative likelihood ratio of 0.21 (95% CI: 0.12-0.38) [corrected] for predicting PE overall, and 0.63 (95% CI: 0.38-1.06) in low-risk patients.
CONCLUSIONS: Our results suggest that the PERC rule alone or even when combined with the revised Geneva score cannot safely identify very low risk patients in whom PE can be ruled out without additional testing, at least in populations with a relatively high prevalence of PE.
© 2011 International Society on Thrombosis and Haemostasis.

Entities:  

Mesh:

Year:  2011        PMID: 21091866     DOI: 10.1111/j.1538-7836.2010.04147.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  6 in total

Review 1.  Diagnosis of suspected venous thromboembolism.

Authors:  Clive Kearon
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

2.  Effect of the Pulmonary Embolism Rule-Out Criteria on Subsequent Thromboembolic Events Among Low-Risk Emergency Department Patients: The PROPER Randomized Clinical Trial.

Authors:  Yonathan Freund; Marine Cachanado; Adeline Aubry; Charlotte Orsini; Pierre-Alexis Raynal; Anne-Laure Féral-Pierssens; Sandrine Charpentier; Florence Dumas; Nacera Baarir; Jennifer Truchot; Thibaut Desmettre; Karim Tazarourte; Sebastien Beaune; Agathe Leleu; Mehdi Khellaf; Mathias Wargon; Ben Bloom; Alexandra Rousseau; Tabassome Simon; Bruno Riou
Journal:  JAMA       Date:  2018-02-13       Impact factor: 56.272

3.  Pulmonary embolism, part I: Epidemiology, risk factors and risk stratification, pathophysiology, clinical presentation, diagnosis and nonthrombotic pulmonary embolism.

Authors:  Jan Bĕlohlávek; Vladimír Dytrych; Aleš Linhart
Journal:  Exp Clin Cardiol       Date:  2013

4.  Previously undiagnosed scoliosis presenting as pleuritic chest pain in the emergency department - a case series and a validating retrospective audit.

Authors:  Gabor Xantus; Derek Burke; Peter Kanizsai
Journal:  BMC Emerg Med       Date:  2021-05-17

5.  PERC rule to exclude the diagnosis of pulmonary embolism in emergency low-risk patients: study protocol for the PROPER randomized controlled study.

Authors:  Yonathan Freund; Alexandra Rousseau; France Guyot-Rousseau; Yann-Erick Claessens; Olivier Hugli; Olivier Sanchez; Tabassome Simon; Bruno Riou
Journal:  Trials       Date:  2015-11-25       Impact factor: 2.279

6.  The use of clinical decision rules for pulmonary embolism in the emergency department: a retrospective study.

Authors:  Omran Al Dandan; Ali Hassan; Afnan Alnasr; Mohammed Al Gadeeb; Hossain AbuAlola; Sarah Alshahwan; Malak Al Shammari; Alaa Alzaki
Journal:  Int J Emerg Med       Date:  2020-05-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.